Download PDF
Horm Metab Res 2001; 33(1): 39-43
DOI: 10.1055/s-2001-12625
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

The Pituitary Response to Ovine Corticotropin-Releasing Hormone is Enhanced in Obese Men and Correlates with Insulin Resistance

M. P.  Solano1 , M. Kumar2 , B. Fernandez, L. Jones, R. B. Goldberg1
  • 1 Department of Medicine, University of Miami School of Medicine, Miami, FL, USA
  • 2 Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL, USA
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in central obesity has been demonstrated in women. We studied the corticotropin (ACTH) and cortisol response to ovine corticotropin releasing hormone (oCRH) and its association to parameters of adiposity and insulin resistance in a group of 19 healthy obese (BMI > 25 kg/m2 ) and 9 non-obese men. Relative insulin resistance was assessed by the homeostatic model assessment (HOMA IR). Baseline ACTH was similar, while cortisol was lower in the obese group. The ACTH response to oCRH was significantly higher in the obese group. ACTH incremental area under the curve (iAUC) correlated with age, HOMA IR, and sagittal diameter but not with leptin. In multiple regression analysis, only HOMA IR was an independent predictor of ACTH iAUC. In conclusion, obese men have hyperactivity of the HPA axis at the pituitary level, which appears to be linked to insulin resistance.

Key words: HPA Axis - Insulin Resistance - Central Obesity

References

  • 1 Blackard W G, Clore J N, Glickman P S, Nestler J E, Kellum J M. Insulin sensitivity of splanchnic and peripheral adipose tissue in vivo in morbidly obese men.  Metabolism. 1987;  64 1169-1173
    PubMedGoogle Scholar
  • 2 Kissebah A H. Insulin resistance in visceral obesity.  Int J Obesity. 1991;  S20 109-115
    PubMedGoogle Scholar
  • 3 Fujioka S, Matzuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.  Metabolism. 1987;  36 54-59
    CrossrefPubMedGoogle Scholar
  • 4 Marin P, Darin N, Amemiya T, Anderson B, Jen S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women.  Metabolism. 1992;  41 882-886
    CrossrefPubMedGoogle Scholar
  • 5 Pasquali R, Cantobelli S, Casimiri F, Capelli M, Bortoluzzi L, Flamia R, Morselli A M, Barbara L. The hypothalamic-pituitary-adrenal axis in women with different patterns of body fat distribution.  J Clin Endocrinol Metab. 1993;  77 341-346
    CrossrefPubMedGoogle Scholar
  • 6 Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimiri F, Vicennati V, Carcello A, Morselli A M. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin releasing factor/arginine-vasopressin test and of stress.  Metabolism. 1996;  45 351-356
    CrossrefPubMedGoogle Scholar
  • 7 Lanzone A, Petraglia F, Fulghesu A M, Ciampelli M, Caruso A, Mancuso S. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropin hormone and cortisol in polycystic ovary syndrome.  Fertil Steril. 1995;  63 1195-1199
    PubMedGoogle Scholar
  • 8 Lanzone A, Guido M, Ciampelli M, Fulghesu A M, Pavone V, Proto C, Caruso A, Mancuso S. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.  Clin Endocrinol (Oxf). 1996;  45 73-77
    CrossrefPubMedGoogle Scholar
  • 9 Bjorntorp P. Endocrine abnormalities of obesity.  Metabolism. 1995;  44 (Suppl 3) 21-23
    CrossrefPubMedGoogle Scholar
  • 10 Ljung T, Andreson B, Bengtsson B A, Bjorntorp B, Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: A dose-response study.  Obes Res. 1996;  4 277-282
    PubMedGoogle Scholar
  • 11 Hautanen A, Raikkonen K, Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.  J Intern Med. 1997;  241 451-461
    PubMedGoogle Scholar
  • 12 Rosmond R, Dallman M F, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.  J Clin Endocrinol Metab. 1998;  83 1853-1859
    CrossrefPubMedGoogle Scholar
  • 13 Wand G S, Schumann H. Relationship between plasma adrenocorticotropin, hypothalamic opioid tone, and plasma leptin.  J Clin Endocrinol Metab. 1998;  83 2138-2142
    CrossrefPubMedGoogle Scholar
  • 14 Elimam A, Knutsson U, Bronnegard M, Stierna P, Alberston-Wikland K, Marcus C. Variations in glucocorticoid levels within the physiological range affect plasma leptin levels.  Eur J Endocrinol. 1998;  139 615-620
    CrossrefPubMedGoogle Scholar
  • 15 Hagan M N, Havel P J, Seely R J, Woods S C, Ekhator N N, Baker D G, Hill K K, Wortman M D, Miller A H, Gingerich R L, Geracioti T D Jr. Cerebrospinal fluid and plasma leptin measurements: covariability with dopamine and cortisol in fasting humans.  J Endocrinol Metab. 1999;  84 3579-3585
    PubMedGoogle Scholar
  • 16 Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.  Diabetes. 1998;  47 890-893
    PubMedGoogle Scholar
  • 17 Schwartz M W, Seeley R J, Campfield L A, Burn P, Baskin D G. Identification of targets of leptin action in rat hypothalamus.  J Clin Invest. 1996;  98 1101-1106
    CrossrefPubMedGoogle Scholar
  • 18 Van Dijk G, Seely R J, Thiele T E, Friedman M I, Ji H, Wilkinson C W, Burn P, Campfield L A, Tenenbaum R, Baskin D G, Woods S C, Schwartz M W. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat.  Am J Physiol. 1999;  276 R1425-1433
    PubMedGoogle Scholar
  • 19 Van Dijk G, Donahey C K, Thiele T E, Scheurink A JW, Steffens A B, Wilkinson C W, Tenenbaum R, Campfield L A, Bum P, Seeley R J, Woods S C. Central leptin stimulates corticosterone secretion at the onset of the dark phase.  Diabetes. 1997;  46 1911-1914
    PubMedGoogle Scholar
  • 20 Ahima R S, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier J S. Role of leptin in the neuroendocrine response to fasting.  Nature. 1996;  382 250-252
    CrossrefPubMedGoogle Scholar
  • 21 Heiman M L, Ahima R S, Craft L S, Schoner B, Stephens T W, Flier J S. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.  Endocrinology. 1997;  138 3859-3863
    CrossrefPubMedGoogle Scholar
  • 22 Licinio J, Mantzoros C, Negrao A B, Cizza G, Wong M, Bongiorno P B, Chorousos G P, Karp B, Allen C, Flier J S, Gold P W. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function.  Nature Med. 1997;  3 575-579
    CrossrefPubMedGoogle Scholar
  • 23 Pralong F P, Roduit R, Waeber G, Castillo E, Mosimann F, Thorens B, Gaillard R C. Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland.  Endocrinology. 1998;  139 4264-4268
    CrossrefPubMedGoogle Scholar
  • 24 Segal K R, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.  Diabetes. 1996;  45 988-991
    PubMedGoogle Scholar
  • 25 Donahue R P, Prineas R J, Donahue R D, Zimmet P, Bean J A, De Courten M, Collier G, Goldberg R B, Skyler J S, Schneiderman N. Is fasting leptin associated with insulin resistance among nondiabetic individuals?.  Diabetes Care. 1999;  22 1092-1096
    PubMedGoogle Scholar
  • 26 Ruige J B, Dekker J M, Blum W F, Stehower C DA, Nijpels G, Mooy J, Kostense P J, Bouter L M, Heine R J. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study.  Diabetes Care. 1999;  22 1097-1104
    PubMedGoogle Scholar
  • 27 Haffner S M, Miettinen H, Mykkanen L, Karhapaa P, Rainwater D L, Laakso M. Leptin concentrations and insulin sensitivity in normoglycemic men.  Int J Obes. 1997;  21 393-399
    CrossrefPubMedGoogle Scholar
  • 28 . World Health Organization .Diabetes Mellitus: Report of a WHO Study Group . Geneva; World Health Org. 1985 (Tech. Rep. Ser. no. 727)
    Google Scholar
  • 29 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R L. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
    Google Scholar
  • 30 Friedewald W T, Levy R S, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge.  Clin Chem. 1972;  18 499-502
    CrossrefPubMedGoogle Scholar
  • 31 Debold C R, Jackson R V, Kamilaris T C, Sheldon W R Jr, Dechemey G S, Island D P, Orth D N. Effects of ovine corticotropin-releasing honnone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.  J Clin Endocrinol Metab. 1989;  68 431-437
    PubMedGoogle Scholar
  • 32 Zamboni M, Turcato E, Armellini F, Kahn H S, Zivelonghi A, Santana H, Bergamo-Andreis I A, Bosello 0. Sagittal abdominal diameter as a practical predictor of visceral fat.  Int J Obes Relat Metab Disord. 1998;  22 655-660
    CrossrefPubMedGoogle Scholar
  • 33 Rosmond R, Bjorntorp P. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men.  Int J Obes. 1998;  22 1184-1196
    CrossrefPubMedGoogle Scholar
  • 34 Fruehwals-Scultes B, Kem W, Bong W, Welhoener P, Kerner W, Born J, Fehm H L, Peters A. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans.  J Clin Endocrinol Metab. 1999;  84 3041-3046
    CrossrefPubMedGoogle Scholar
  • 35 Schwartz M W, Figlewicz D P, Baskin D G, Woods S C, Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance.  Endocr Rev. 1992;  13 387-413
    CrossrefPubMedGoogle Scholar
  • 36 Unger J W, Lange W. Insulin receptors in the pituitary gland: morphological evidence for influence on opioid peptide synthesizing cell.  Cell Tissue Res. 1997;  288 471-483
    CrossrefPubMedGoogle Scholar
  • 37 Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L, Casimiri F. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome.  Int J Obes. 1999;  23 419-424
    CrossrefPubMedGoogle Scholar

M. P. Solano

Department of Medicine

University of Miami School of Medicine
1450 NW 10th Avenue R-77
Miami, FL 33136
USA


Phone: Phone:+ 1 (305) 243-2328

Fax: Fax:+ 1 (305) 243-1200

Email: E-mail:msolano@med.miami.edu

      >